DANBURY, Conn. (Feb. 11, 2014) – Odyssey Logistics & Technology Corporation (“OL&T”), today announced its acceptance of a non-controlling capital investment from Goldman, Sachs & Co. (NYSE: GS). OL&T has indicated that the capital will be used in its ongoing programs of strategic acquisitions and global expansion. “This is an exciting time for Odyssey,” said […]
This author has yet to write their bio.Meanwhile lets just say that we are proud admin contributed a whooping 40 entries.
Entries by admin
Auspex Announces Completion Of Initial Public Offering And Exercise In Full Of Underwriters’ Over-Allotment Option LA JOLLA, Calif., Feb. 10, 2014 /PRNewswire/ — Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced the completion of its initial public offering of 8,050,000 shares of its common […]
SOUTH SAN FRANCISCO, Calif., Aug. 19, 2013 /PRNewswire/ — Velocity Pharmaceutical Development, LLC (“VPD”) and Tigercat Pharma, Inc., (“Tigercat”) announced today the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for VPD-737 for the treatment of chronic pruritus. Tigercat licensed worldwide rights to VPD-737 (Serlopitant), an NK-1 receptor antagonist, from […]
Extending 3DEXPERIENCE to Global Manufacturing Operations Management Market and Expanding Addressable Market Opportunity VÉLIZY-VILLACOUBLAY, France — July 2, 2013 —Dassault Systèmes (Euronext Paris: #13065, DSY.PA), the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, today announced the completion of the acquisition of Apriso, a leading […]
Japan-based Takeda Pharmaceuticals, which has its cancer drug development operations in Cambridge, MA, said today it is acquiring San Diego-based Intellikine to get ahold of the startup’s portfolio of cancer drugs. Takeda said it has agreed to pay $190 million upfront, plus another $120 million in future milestone payments, to acquire privately held Intellikine. Through this deal, […]